Genomic and Genetic Characterization of Cholangiocarcinoma Identifies Therapeutic Targets for Tyrosine Kinase Inhibitors
Jesper B. Andersen, Bart Spee(KU Leuven), Boris Blechacz(Mayo Clinic), Itzhak Avital(National Institutes of Health), Mina Komuta(KU Leuven), Andrew P. Barbour(University of Queensland), Elizabeth A. Conner(National Institutes of Health), Matthew C. Gillen(National Institutes of Health), Tania Roskams(KU Leuven), Lewis R. Roberts(Mayo Clinic), Valentina M. Factor(National Institutes of Health), Snorri S. Thorgeirsson(National Institutes of Health)
Cited by 552
Abstract
Related Papers
No related papers found
Powered by citation graph analysis